These findings suggest that TanCAR-T cells have therapeutic potential to improve GBM control by co-engaging HER2 and IL13Rα2 in an enhanced, bivalent immune synapse that strengthens T cell functionality and reduces antigen escape (53). This evidence concerns the gene ERBB2 and glioblastoma.